They are preparing for everything. Patience. They will have the presence when they can keep up with the incredible demand. A great business plan ahead. In the meantime soak up those shares and say let's go.
That would take a marketing budget and staff which they are not capitalized to handle. That’s why it make no sense that a pharma with supposedly disruptive tech would exclusively license anything to Gpft who’s only accomplishment is to have processing and a distribution license but is unable to turn a profit or at least break even!